Tabituximab
Modify Date: 2024-04-08 16:34:07
Tabituximab structure
|
Common Name | Tabituximab | ||
|---|---|---|---|---|
| CAS Number | 1644134-10-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TabituximabTabituximab (OTSA101) is a humanized monoclonal antibody against frizzled class receptor 10 (FZD10)[1]. |
| Name | Tabituximab |
|---|
| Description | Tabituximab (OTSA101) is a humanized monoclonal antibody against frizzled class receptor 10 (FZD10)[1]. |
|---|---|
| Related Catalog | |
| Target |
FZD10[1] |
| In Vitro | 非放射标记的 Tabituximab (OTSA101) 抗体对滑膜肉瘤细胞生长只有较弱的拮抗活性[1]。 |
| In Vivo | Yttrium 90 放射标记的 OTSA101 (OTSA101-DTPA-90Y) 在小鼠异种移植模型静脉单次注射后显示出显著的抗肿瘤活性[1]。 |
| References |
[1]. Blagodatski A, et al. Targeting the Wnt pathways for therapies. Mol Cell Ther. 2014 Sep 11;2:28. |
| No Any Chemical & Physical Properties |